glp-1 news oct 21 2025 Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders GLP-1 therapies are changing obesity

Studies have shown that patients on these medications, combined with lifestyle changes, can achieve substantial weight loss, often in the range of 15% to over 20% of their total body weight, making them a powerful tool in the fight against obesity

Regions of interest were drawn around Fura-2-AM-loaded cells under 40 magnification as well as around one region of the field devoid of cells, which was to be used as the background

11 While typically associated with aging, rapid weight loss without adequate attention to muscle preservation could potentially accelerate this decline, making functional strength a key consideration during a GLP-1 journey

Sharp, L